Attached files
file | filename |
---|---|
EX-99.1 - EARNINGS RELEASE - China Botanic Pharmaceutical | v208930_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): January 25, 2011
CHINA
BOTANIC PHARMACEUTICAL INC.
(Exact
name of Registrant as Specified in its Charter)
Nevada
|
0-24512
|
88-1273503
|
||
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(IRS
Employer
Identification
No.)
|
No.
281, Taiping Road, Taiping District
Harbin,
Heilongjiang Province, 150050
(Address
of Principal Executive Offices)
Registrant’s
telephone number, including area code: 86-451-5762-0378
Renhuang
Pharmaceuticals, Inc.
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
ITEM
2.02. Results of Operations and Financial Condition
On
January 25, 2011, China Botanic Pharmaceutical Inc. (the “Company”) issued a
press release announcing the Company’s financial results for the three months
and fiscal year ended October 31, 2010. A copy of this press release is attached
hereto as Exhibit 99.1.
The
information in this Item 2.02 of Form 8-K, including the accompanying
exhibit, shall not be deemed to be “filed” for the purposes of Section 18
of the Securities and Exchange Act of 1934 (the “Exchange Act”), or
otherwise subject to the liability of such section, nor shall such information
be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, regardless of the general incorporation
language of such filing, except as shall be expressly set forth by specific
reference in such filing.
Item
9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit
No.
|
Description
|
|
99.1*
|
Press
Release dated January 25, 2011 announcing fourth quarter and full-year
2010 financial results
|
*
|
Such
Exhibit is being “furnished” (not filed) pursuant to Item 2.02 of the
Current Report on Form 8-K.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
CHINA
BOTANIC PHARMACEUTICAL INC.
|
||
Date:
January 25, 2011
|
By:
|
/s/ Shaoming
Li
|
Shaoming
Li
|
||
Chief
Executive Officer
|
EXHIBIT
INDEX
Exhibit
No.
|
Description
|
|
99.1*
|
Press
Release dated January 25, 2011 announcing fourth quarter and full-year
2010 financial results
|
*
|
Such
Exhibit is being “furnished” (not filed) pursuant to Item 2.02 of the
Current Report on Form 8-K.
|